12:00 AM
 | 
Oct 08, 2012
 |  BioCentury  |  Finance

Rewarding the crowd

French antibacterial play Antabio finds exit for crowd-sourced seed investors
Rewarding the crowd

While questions remain about how and when a crowd-funding mechanism will be put in place in the U.S., a French biotech last week said its crowd-sourced seed investors achieved a successful exit.

Antabio SAS raised €300,000 ($386,000) in seed money from more than 200 investors through WiSeed, a French crowd-funding platform in which individuals can invest a minimum of €100.

The antibacterial play is...

Read the full 307 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >